GHENT, Belgium, June 01, 2021 (GLOBE NEWSWIRE) – Remedent, Inc. (OTCBB: REMI.OB), an international company engaged in the research, development and manufacture of dental care and cosmetic dentistry products, announces its agreement to supply GlamSmile Veneers and Technologies to Aurum Ceramic Dental Laboratories Co., for the territory of North America.
Under this agreement, Remedent will supply GlamSmile veneers and proprietary tray technology to Aurum Ceramic Dental Laboratories Co., the licensee.
Aurum Ceramic Dental Laboratories Co. will use its best efforts to develop the largest market possible to sell and promote Remedent’s GlamSmile veneers.
Remedent continues to innovate and has undergone a major overhaul of its business model as we focus on more dedicated clinics and organizations. Remedent continues to refine the digital veneer workflow with new software releases to make GlamSmile a turnkey solution that includes solutions for the design, production and placement of unique marketing and imaging software platforms.
“This license agreement is important to us in that it will expand our active presence in North America, offering our leading approach to GlamSmile Veneers, Technology and Smile consulting to US-based clients,” commented Mr. Guy De Vreese, CEO of Remedent. “We look forward to this new cooperation and believe that with this partnership we are at the beginning of a win-win cooperation that will better inform, support and attract new patients in the field of cosmetic dentistry with support. and quality products. “
“Aurum strives to partner with leaders in dentistry with a clear goal: to provide our clients and their patients with exceptional functional and aesthetic dentistry. We are very proud to have been chosen by Remedent to be the exclusive North American partner to bring highly innovative and proven emerging technology that dramatically improves chairside performance and superior patient outcomes. For us, together with Remedent, we aim to bring a new level of predictability, quality and patient impact to healthy new smiles, ”said Mark Maier, CEO of The Aurum Group.
Remedent Inc. creates cutting-edge dental technologies and marketing concepts. Famous brands are GlamSmile, Remecure, Smile Me and River 8. Based in Belgium, Remedent Inc. manufactures, markets and distributes its products and concepts in more than 25 countries around the world. Remedent Inc. is publicly traded and focuses on B2B, providing products to the dental professional, as well as B2C approaches, helping consumers achieve the smile of their dreams through its smile counseling concept.
About the Aurum Group:
Aurum, an industry leader in comprehensive cosmetic dentistry, is the largest group of laboratories in Canada and the 3rd or 4e largest in North America. Celebrating 50 years in business, Aurum has become the leader in all aspects of smile design. Our Aurum Group family has grown and evolved from Mr. Hans “Hyo” Maier to a fully diversified dental company with over 450 employees across North America. Although our company’s services and operations have grown and quickly become the benchmark in many dental industries, our underlying principles, passion and drive have remained steadfast; we do it for the love of smiles ™.
For more information, please contact:
Mr. Philippe Van Acker
Zuiderlaan 1-3 box 8, 9000 Gent – Belgium
E: [email protected]
Declaration under the Private Securities Litigation Reform Act 1995
Statements in this press release that are “forward-looking statements” are based on current expectations and assumptions that are subject to risks and uncertainties. These forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Remedent’s actual operating results to differ materially from any historical results or from any future results expressed or implied in such statements. prospective. In addition to statements which explicitly describe these risks and uncertainties, readers are cautioned to consider statements containing terms such as “believes”, “belief”, “expects”, “expects”, “has the” intention “,” intends “,” anticipates, “” anticipates “,” plans “,” plans “,” projects “,” project “, to be uncertain and forward-looking. Actual results could differ materially due to factors such as Remedent’s ability to realize the synergies and value creation envisioned by the proposed transaction. For more information on the risks and uncertainties associated with Remedent’s business, please refer to the risk factors described in the documents filed by Remedent with the Securities and Exchange Commission, including, but not limited to its report. annual report on form 10-K and its quarterly reports on form 10 -Q.